Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Ollin Biosciences, Inc.

Ollin Biosciences, Inc.

Stage unknownAustin, TXBiotechnology
Facts
Year of incorporation
2022sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. May 14, 2026
    Form D equity offering · $156M (form d sold) · 32 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Ollin Biosciences, Inc. filed Form D: $156,249,990 sold of $330,000,000, Biotechnology”
Investors on record
1 edges
People
1 officers, 7 directors
Timeline
1
  1. Jun 24, 2026
    Ollin Biosciences, Inc. filed Form D: $156,249,990 sold of $330,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company